GEROSTATE ALPHA
Gerostate Alpha is tackling human aging, an ambitious goal. The three co-founders are all academics at the Buck Institute where they’ve spent years researching aging. They’ve used their proprietary platform for drug discovery to quickly parse 90,000 compounds and identify 150 hits for further research.
GEROSTATE ALPHA
Industry:
Biotechnology Medical
Founded:
2018-01-01
Address:
Novato, California, United States
Country:
United States
Website Url:
http://www.gerostatealpha.com
Total Employee:
1+
Status:
Active
Total Funding:
150 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail PHP
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Investors List
Sand Hill Angels
Sand Hill Angels investment in Seed Round - Gerostate Alpha
CRCM Ventures
CRCM Ventures investment in Seed Round - Gerostate Alpha
Longevitytech.fund
Longevitytech.fund investment in Seed Round - Gerostate Alpha
Y Combinator
Y Combinator investment in Pre Seed Round - Gerostate Alpha
Official Site Inspections
http://www.gerostatealpha.com Semrush global rank: 5.27 M Semrush visits lastest month: 1.56 K
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 13.248.243.5
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Gerostate Alpha"
Gerostate Alpha - Crunchbase Company Profile
Gerostate Alpha is tackling human aging, an ambitious goal. The three co-founders are all academics at the Buck Institute where they’ve spent years …See details»
Gerostate Alpha 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Gerostate Alpha. Use the PitchBook Platform to explore the full profile.See details»
GeroState Alpha Company Profile | Management and Employees …
Find contact information for GeroState Alpha. Learn about their Business Services market share, competitors, and GeroState Alpha's email format.See details»
Who's Who in Gerontology: Gerostate Alpha
Gerostate Alpha Summary CEO Simon Melov Area of work Pharmaceutical company that aims to develop breakthrough pharmaceuticals to mitigate and reduce the effects of aging.See details»
Gerostate Alpha (YC S18): A pharmaceutical company dedicated to ...
Raised from 472 investors Pitch Video Investor Panel gerostatealpha.com San Francisco, CA Technology B2B Biotech Overview DetailsSee details»
Gerostate Alpha Company Profile - Office Locations, Competitors …
See insights on Gerostate Alpha including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Gerostate Alpha Incorporated Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Gerostate Alpha Incorporated of Novato, CA. Get the latest business insights from Dun & Bradstreet.See details»
GeroState Alpha - Overview, News & Similar companies - ZoomInfo
View GeroState Alpha (www.gerostatealpha.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Gerostate Alpha, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Jul 10, 2023 Holding Company| 2018| California, United States | www.gerostatealpha.com Holding Company| 2018| California, United States | www.gerostatealpha.com Last update 31 …See details»
Gerostate Alpha - Longevity List
About Gerostate Alpha is a new pharmaceutical company dedicated to treating aging and age-related disease. Incubating at the Buck Institute for Research on Aging, we develop …See details»
BiohackingCongress - Startup - Gerostate Alpha
Gerostate Alpha is a biotech company focused on developing therapeutics for aging. Aging is the single largest biomedical problem in the world, with annual costs in the trillions. We believe the …See details»
GeroState Alpha - 2025 Company Profile & Team - Tracxn
Jun 20, 2025 GeroState Alpha - Developer of drugs for treating aging and age-related disease. Raised a total funding of $150K over 1 round from 6 investors.See details»
Gerostate Alpha - VentureRadar
Gerostate Alpha is a new pharmaceutical company dedicated to treating aging and age-related disease. Incubating at the Buck Institute for Research on Aging, we develop breakthrough …See details»
Gerostate Alpha - Y Combinator
Developing novel therapeutics for aging and chronic disease. Founded in by , Gerostate Alpha has 6 employees based in Novato, CA, USA.See details»
Gerostate Alpha: "Our phenotype is lifespan"
Jan 19, 2021 Gerostate Alpha's founders talk increasing lifespan, drug discovery, indications and raising funding for anti-aging interventions.See details»
A Profile of Buck Institute Startup Company Gerostate Alpha
Jan 27, 2021 A sizable fraction of the startup biotech companies in the small but growing longevity industry are essentially screening programs, in that they are developing various …See details»
Gerostate Alpha - VentureRadar
"Gerostate Alpha is a new pharmaceutical company dedicated to treating aging and age-related disease. Incubating at the Buck Institute for Research on Aging, we develop breakthrough …See details»
Gerostate Alpha - Products, Competitors, Financials, Employees ...
About Gerostate Alpha Gerostate Alpha is a pharmaceutical company focused on developing treatments for aging and age-related diseases. They create breakthrough pharmaceuticals …See details»
Gerostate Alpha opens crowdfunded capital raise
Apr 14, 2021 Buck Institute-founded start-up Gerostate Alpha seeks to crowdfund its biotech platform – more democratising of longevity.See details»
Gerostate Alpha - lifesciencehistory.com
Gerostate Alpha is a new pharmaceutical company dedicated to treating aging and age-related disease.See details»